Trial Profile
Phase III Study of Immune Globulin Intravenous (Human) IGIV-SN in Pediatric Subjects With Primary Humoral Immunodeficiency
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2020
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors GC Biopharma
- 09 Jul 2020 Status changed from withdrawn prior to enrolment to not yet recruiting.
- 01 Jul 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 16 Apr 2018 New trial record